Maria Galkin

Oncology

1 Essex Center Drive
Peabody, MA 01960

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 4 publications

A phase II trial of decitabine, bortezomib and pegylated liposomal doxorubicin for the treatment of relapsed or refractory AML.

A phase II trial of decitabine, bortezomib and pegylated liposomal doxorubicin for the treatment of relapsed or refractory AML.

Journal: Leukemia research reports

Published: February 26, 2023

Enasidenib in the treatment of relapsed/refractory acute myeloid leukemia: an evidence-based review of its place in therapy.

Enasidenib in the treatment of relapsed/refractory acute myeloid leukemia: an evidence-based review of its place in therapy.

Journal: Core evidence

Published: December 23, 2018

Diagnostic Dilemma: Carcinoid Syndrome.

Diagnostic Dilemma: Carcinoid Syndrome.

Journal: The American journal of medicine

Published: May 13, 2018

Breast cancer-specific survival in patients with HER2-positive, node-negative T1a and T1b breast cancer.

Breast cancer-specific survival in patients with HER2-positive, node-negative T1a and T1b breast cancer.

Journal: Cancer treatment and research communications

Published: January 01, 2018

Showing 1-4 of 4

Last Updated: 09/26/2026